A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis.

Rheumatoid arthritis (RA) is the most common systemic autoimmune disease, affecting approximately 1% of the adult population worldwide, with an estimated heritability of 60%. To identify genes involved in RA susceptibility, we investigated the association between putative functional single-nucleotide polymorphisms (SNPs) and RA among white individuals by use of a case-control study design; a second sample was tested for replication. Here we report the association of RA susceptibility with the minor allele of a missense SNP in PTPN22 (discovery-study allelic P=6.6 x 10(-4); replication-study allelic P=5.6 x 10(-8)), which encodes a hematopoietic-specific protein tyrosine phosphatase also known as "Lyp." We show that the risk allele, which is present in approximately 17% of white individuals from the general population and in approximately 28% of white individuals with RA, disrupts the P1 proline-rich motif that is important for interaction with Csk, potentially altering these proteins' normal function as negative regulators of T-cell activation. The minor allele of this SNP recently was implicated in type 1 diabetes, suggesting that the variant phosphatase may increase overall reactivity of the immune system and may heighten an individual carrier's risk for autoimmune disease.

[1]  N. Breslow,et al.  Statistical methods in cancer research: volume 1- The analysis of case-control studies , 1980 .

[2]  James J Schlesselman.  Case-Control Studies: Design, Conduct, Analysis , 1982 .

[3]  J. Cloutier,et al.  Association of inhibitory tyrosine protein kinase p50csk with protein tyrosine phosphatase PEP in T cells and other hemopoietic cells. , 1996, The EMBO journal.

[4]  N. Kamatani,et al.  Identification of the gene loci that predispose to rheumatoid arthritis. , 1998, International immunology.

[5]  G. Gyapay,et al.  New susceptibility locus for rheumatoid arthritis suggested by a genome-wide linkage study. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[6]  Jing-Ping Lin,et al.  Familial clustering of rheumatoid arthritis with other autoimmune diseases , 1998, Human Genetics.

[7]  J. Cloutier,et al.  Sequence Requirements for Association of Protein-tyrosine Phosphatase PEP with the Src Homology 3 Domain of Inhibitory Tyrosine Protein Kinase p50 csk * , 1998, The Journal of Biological Chemistry.

[8]  J. Trent,et al.  Clustering of non-major histocompatibility complex susceptibility candidate loci in human autoimmune diseases. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[9]  J. Cloutier,et al.  Cooperative Inhibition of  T-Cell Antigen Receptor Signaling by a Complex between a Kinase and a Phosphatase , 1999, The Journal of experimental medicine.

[10]  P. Gregersen,et al.  The genetics revolution and the assault on rheumatoid arthritis. , 1999, Arthritis and rheumatism.

[11]  E. Shaoul,et al.  Cloning and characterization of a lymphoid-specific, inducible human protein tyrosine phosphatase, Lyp. , 1999, Blood.

[12]  M. M. Griffiths,et al.  Mapping autoimmunity genes. , 1999, Current opinion in immunology.

[13]  Daniel F. Gudbjartsson,et al.  Allegro, a new computer program for multipoint linkage analysis , 2000, Nature genetics.

[14]  M. Weiner,et al.  Multiplexed single nucleotide polymorphism genotyping by oligonucleotide ligation and flow cytometry. , 2000, Cytometry.

[15]  A S Rigby,et al.  Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins. , 2000, Arthritis and rheumatism.

[16]  Jan Mous,et al.  Touching base , 2000, Nature Genetics.

[17]  S. Germer,et al.  High-throughput SNP allele-frequency determination in pooled DNA samples by kinetic PCR. , 2000, Genome research.

[18]  Philippa Marrack,et al.  Autoimmune disease: why and where it occurs , 2001, Nature Medicine.

[19]  E. Wakeland,et al.  The genetics of complex autoimmune diseases: non-MHC susceptibility genes , 2001, Nature Immunology.

[20]  T. Sumida,et al.  Dysfunction of T cell receptor AV24AJ18+, BV11+ double-negative regulatory natural killer T cells in autoimmune diseases. , 2001, Arthritis and rheumatism.

[21]  C I Amos,et al.  A genomewide screen in multiplex rheumatoid arthritis families suggests genetic overlap with other autoimmune diseases. , 2001, American journal of human genetics.

[22]  M. Gishizky,et al.  The lymphoid protein tyrosine phosphatase Lyp interacts with the adaptor molecule Grb2 and functions as a negative regulator of T-cell activation. , 2002, Experimental hematology.

[23]  Wei Chen,et al.  Dissecting the genetic complexity of the association between human leukocyte antigens and rheumatoid arthritis. , 2002, American journal of human genetics.

[24]  F. Wolfe,et al.  HLA-DRB1 genotype associations in 793 white patients from a rheumatoid arthritis inception cohort: frequency, severity, and treatment bias. , 2002, Arthritis and rheumatism.

[25]  N. Dalbeth,et al.  A subset of natural killer cells is greatly expanded within inflamed joints. , 2002, Arthritis and rheumatism.

[26]  Paul Wordsworth,et al.  Whole-genome linkage analysis of rheumatoid arthritis susceptibility loci in 252 affected sibling pairs in the United Kingdom. , 2002, Arthritis and rheumatism.

[27]  S. Fisher,et al.  Meta-analysis of four rheumatoid arthritis genome-wide linkage studies: confirmation of a susceptibility locus on chromosome 16. , 2003, Arthritis and rheumatism.

[28]  Yusuke Nakamura,et al.  Functional haplotypes of PADI 4 , encoding citrullinating enzyme peptidylarginine deiminase 4 , are associated with rheumatoid arthritis , 2003 .

[29]  Yusuke Nakamura,et al.  Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis , 2003, Nature Genetics.

[30]  Xiangli Xiao,et al.  Screening the genome for rheumatoid arthritis susceptibility genes: a replication study and combined analysis of 512 multicase families. , 2003, Arthritis and rheumatism.

[31]  L. Shih,et al.  Characterization of a Myeloid Tyrosine Phosphatase, Lyp, and Its Role in the Bcr-Abl Signal Transduction Pathway* , 2003, Journal of Biological Chemistry.

[32]  Yusuke Nakamura,et al.  An intronic SNP in a RUNX1 binding site of SLC22A4, encoding an organic cation transporter, is associated with rheumatoid arthritis , 2003, Nature Genetics.

[33]  D. Botstein,et al.  Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease , 2003, Nature Genetics.

[34]  M. Khoury,et al.  On the Use of Population Attributable Fraction to Determine Sample Size for Case-Control Studies of Gene-Environment Interaction , 2003, Epidemiology.

[35]  G. Firestein.  Evolving concepts of rheumatoid arthritis , 2003, Nature.

[36]  Nunzio Bottini,et al.  A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes , 2004, Nature Genetics.

[37]  M. Boehnke,et al.  Assessing whether an allele can account in part for a linkage signal: the Genotype-IBD Sharing Test (GIST). , 2004, American journal of human genetics.

[38]  L. Diehl,et al.  PEST Domain-Enriched Tyrosine Phosphatase (PEP) Regulation of Effector/Memory T Cells , 2004, Science.